Gypravastin 20 mg Rosuvastatin Cardiovascular Care - 28 Film Coated Tablets

Manage and optimize your cardiovascular health with Gypravastin 20 mg Film Coated Tablets (28 Tablets). Formulated with Rosuvastatin, a highly effective HMG-CoA reductase inhibitor (statin), this premium cardiovascular medication by Gypto Pharma is clinically proven to reduce high levels of LDL cholesterol and triglycerides while actively increasing protective HDL cholesterol. It plays a critical role in stabilizing arterial plaques, preventing atherosclerosis, and lowering the long-term risk of heart attacks and strokes when combined with a balanced diet. Each box contains 28 film-coated tablets distributed across 4 strips of 7 tablets for simple weekly management.

Advanced Cholesterol Regulation: Formulated with 20 mg Rosuvastatin to actively lower "bad" LDL cholesterol and triglycerides.
Cardiovascular Risk Reduction: Helps slow the progression of atherosclerosis and reduces the long-term risk of stroke or heart attack.
Premium Manufacturing: Developed by Gypto Pharma under strict pharmaceutical quality control regulations.
Convenient Weekly Strips: Packaged in 4 strips of 7 film-coated tablets each for convenient, error-free daily dosing schedules.
Film-Coated Design: Specifically coated tablets to ensure easy swallowing and optimized absorption within the gastrointestinal tract.

EGP 129EGP 140

In Stock

Delivery to governorates within 3-4 working days

Easy returns within 14 days

Specifications

SKU	ISG017119
Color	Luscious Blackberry
UPC	6224008874089

About the product›

Gypravastin 20 mg Tablets – Your Premium Solution for Advanced Cholesterol Management and Heart Protection

Take proactive control of your heart health and lipid levels with Gypravastin 20 mg Film Coated Tablets. Manufactured to international standards by Gypto Pharma, this prescription medication contains Rosuvastatin (20 mg), one of the most potent and clinically trusted statins available for cardiovascular therapy. Gypravastin is primary therapy for individuals diagnosed with primary hypercholesterolemia, mixed dyslipidemia, or those requiring intensive management to mitigate chronic cardiovascular risks.

The active mechanism of Gypravastin 20 mg works by selectively inhibiting HMG-CoA reductase, the essential liver enzyme responsible for synthesizing cholesterol. By lowering liver cholesterol production, it prompts hepatic cells to pull circulating "bad" LDL cholesterol out of the bloodstream, resulting in cleaner, clearer arteries. Concurrently, it helps lower triglycerides and raises "good" HDL cholesterol, working symmetrically to balance your entire lipid profile.

Key Therapeutic Benefits & Performance Qualities:

Targeted Lipid Control: Rapidly lowers high plasma levels of Low-Density Lipoproteins (LDL) and triglycerides.
Arterial Plaque Stabilization: Aids in preventing the dangerous buildup of fatty fatty plaques inside the arterial walls, minimizing the risks of atherosclerosis.
Durable Cardiac Defense: Significantly drops the incidence rate of major cardiac events like stroke, myocardial infarction, and vascular revascularization procedures.
Structured Patient Compliance: The box contains 28 tablets organized precisely into 4 strips $\times$ 7 film-coated tablets, aligning flawlessly with standard 4-week prescription courses.

Directions for Safe and Proper Administration:

Gypravastin 20 mg tablets must be taken exactly as prescribed by your treating cardiologist or physician. The tablet should be swallowed whole with a glass of water, with or without food, preferably at the same time each day (evening administration is often recommended for maximum efficiency). Do not alter or cease your daily dose without consulting your doctor. To achieve peak therapeutic outcomes, maintain a heart-healthy, low-fat diet and participate in regular moderate physical exercise as advised by your healthcare provider.